Princiotta Michael F, Finzi Diana, Qian Shu-Bing, Gibbs James, Schuchmann Sebastian, Buttgereit Frank, Bennink Jack R, Yewdell Jonathan W
Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, USA.
Immunity. 2003 Mar;18(3):343-54. doi: 10.1016/s1074-7613(03)00051-7.
Using L929 cells, we quantitated the macroeconomics of protein synthesis and degradation and the microeconomics of producing MHC class I associated peptides from viral translation products. To maintain a content of 2.6 x 10(9) proteins, each cell's 6 x 10(6) ribosomes produce 4 x 10(6) proteins min(-1). Each of the cell's 8 x 10(5) proteasomes degrades 2.5 substrates min(-1), creating one MHC class I-peptide complex for each 500-3000 viral translation products degraded. The efficiency of complex formation is similar in dendritic cells and macrophages, which play a critical role in activating T cells in vivo. Proteasomes create antigenic peptides at different efficiencies from two distinct substrate pools: rapidly degraded newly synthesized proteins that clearly represent defective ribosomal products (DRiPs) and a less rapidly degraded pool in which DRiPs may also predominate.
利用L929细胞,我们对蛋白质合成与降解的宏观经济学以及从病毒翻译产物中产生与MHC I类相关肽的微观经济学进行了定量分析。为维持2.6×10⁹个蛋白质的含量,每个细胞的6×10⁶个核糖体每分钟产生4×10⁶个蛋白质。每个细胞的8×10⁵个蛋白酶体每分钟降解2.5个底物,每降解500 - 3000个病毒翻译产物就产生一个MHC I类 - 肽复合物。复合物形成的效率在树突状细胞和巨噬细胞中相似,它们在体内激活T细胞中起关键作用。蛋白酶体从两个不同的底物库以不同效率产生抗原肽:快速降解的新合成蛋白质,这些蛋白质显然代表有缺陷的核糖体产物(DRiPs),以及一个降解速度较慢的库,其中DRiPs可能也占主导。